Cara Therapeutics Stock (NASDAQ: CARA) stock price, news, charts, stock research, profile.
Open | $0.28 |
Close | $0.26 |
Volume / Avg. | 6.22M / 590.75K |
Day Range | 0.26 - 0.31 |
52 Wk Range | 0.24 - 4.45 |
Market Cap | $15.17M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 31 |
Short Interest | 4.83% |
Days to Cover | 2.83 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cara Therapeutics (NASDAQ:CARA) through any online brokerage.
Other companies in Cara Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), Cocrystal Pharma (NASDAQ:COCP), Kiora Pharmaceuticals (NASDAQ:KPRX) and Universe Pharmaceuticals (NASDAQ:UPC).
There is no analysis for Cara Therapeutics.
Cara Therapeutics has a consensus price target of $9.78.
The stock price for Cara Therapeutics (NASDAQ: CARA) is $0.2774 last updated June 28, 2024 at 5:37 PM EDT.
There are no upcoming dividends for Cara Therapeutics.
Cara Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Cara Therapeutics.
Cara Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.